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In response to myocardial infarction (MI), quiescent cardiac fibroblasts differentiate into myofibroblasts medi
ating tissue repair. One of the most widely accepted markers of myofibroblast differentiation is the expression of
Acta2 which encodes smooth muscle alpha-actin (SMαA) that is assembled into stress fibers. However, the
requirement of Acta2/SMαA in the myofibroblast differentiation of cardiac fibroblasts and its role in post-MI
cardiac repair remained unknown. To answer these questions, we generated a tamoxifen-inducible cardiac
fibroblast-specific Acta2 knockout mouse line. Surprisingly, mice that lacked Acta2 in cardiac fibroblasts had a
normal post-MI survival rate. Moreover, Acta2 deletion did not affect the function or histology of infarcted
hearts. No difference was detected in the proliferation, migration, or contractility between WT and Acta2-null
cardiac myofibroblasts. Acta2-null cardiac myofibroblasts had a normal total filamentous actin level and total
actin level. Acta2 deletion caused a significant compensatory increase in the transcription level of non-Acta2
actin isoforms, especially Actg2 and Acta1. Moreover, in myofibroblasts, the transcription levels of cytoplasmic
actin isoforms were significantly higher than those of muscle actin isoforms. In addition, we found that
myocardin-related transcription factor-A is critical for myofibroblast differentiation but is not required for the
compensatory effects of non-Acta2 isoforms. In conclusion, the Acta2 deletion does not prevent the myofibroblast
differentiation of cardiac fibroblasts or affect the post-MI cardiac repair, and the increased expression and stress
fiber formation of non-SMαA actin isoforms and the functional redundancy between actin isoforms are able to
compensate for the loss of Acta2 in cardiac myofibroblasts.

1. Introduction

myocardium are permanently lost, which greatly compromises the
integrity of the infarcted ventricle wall [3]. Quiescent cardiac fibroblasts
are quickly activated after MI, characterized by massive proliferation
and myofibroblast differentiation [4], which is believed to be induced by
mechanical stress and cytokine stimulation [5,6]. Myofibroblasts
mediate the formation of infarct scars through expressing high levels of

Among cardiovascular diseases (CVDs), the leading causes of death
in developed countries, acute myocardial infarction (MI) is one of the
most deadly forms due to its unpredictability, fast disease progression,
and poor prognosis [1,2]. Following MI, cardiomyocytes in the infarcted
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lentivirus expressing shRNA targeting mouse Mrtfa; MI, myocardial infarction; MRTFA, myocardin-related transcription factor-A; SkMαA, skeletal muscle alpha-actin;
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extracellular matrix (ECM) proteins and ECM remodeling enzymes
[4,7]. In addition, myofibroblasts are also known for actin stress fibers
mostly composed of smooth muscle alpha-actin (SMαA) encoded by
Acta2 [8,9]. We recently reported that the myofibroblast state of cardiac
fibroblasts was largely limited to the first week after MI, after which
myofibroblasts further differentiated into matrifibrocytes, a newly
identified fibroblast differentiation state lacking the expression of
myofibroblast marker genes [4]. The transient myofibroblast state of
cardiac fibroblasts suggests that myofibroblasts are especially important
in the early stage of post-MI cardiac repair. Indeed, depletion of myo
fibroblasts after MI increased the risk of cardiac rupture during the first
week after MI [7].
Due to the importance of ECM in post-MI tissue healing, the role of
cardiac fibroblasts/myofibroblasts in ECM production and remodeling
has received special attention [10–13]. However, the function of SMαA,
the hallmark of myofibroblasts, has been largely overlooked. A limited
number of early in vitro studies manipulating SMαA level or activity
found that SMαA promoted fibroblast contraction but inhibited cell
migration [14,15]. A later study showed that in myofibroblasts SMαA
stress fibers play an important role in the formation of supermature focal
adhesions which are important for the anchorage of myofibroblasts to
the surrounding ECM [16,17]. Several previous studies using mice with
global Acta2 deletion to investigate the function of SMαA in myofibro
blasts in different disease models suggest that SMαA stress fibers may
regulate or affect myofibroblast proliferation, motility, contractility, and
ECM remodeling [18–20]. However, some discrepancies are present
among the results reported by these studies, which suggests that the role
and necessity of SMαA in myofibroblasts of different origins may vary
significantly. In addition, the deletion of Acta2 in other cell types, such
as the vascular smooth muscle cell, may also affect the interpretation of
the function of SMαA in studies using global Acta2 knockout (KO) mice.
Here, we studied the function of SMαA in cardiac myofibroblasts and
post-MI cardiac repair using a novel tamoxifen-inducible cardiac
fibroblast-specific Acta2 KO mouse line and cardiac fibroblast lineage
tracing. It was found that Acta2 deletion in cardiac fibroblasts did not
significantly affect the post-MI survival or cardiac function of mice. In
response to MI or transforming growth factor β (TGFβ) treatment, Acta2null cardiac fibroblasts underwent normal myofibroblast differentiation,
which was likely due to the compensatory effect of other actin isoforms.

age [23]. Briefly, mice were anesthetized using isoflurane by a ventilator
at 1–3% throughout the entire course of the procedure. Anesthesia was
monitored by a combination of movement, stimulus perception, and
chest wall movement observation. A left lateral thoracotomy was then
performed. The left coronary artery was identified and ligated just below
the left atrium. To ensure the efficient deletion of Acta2, mice were given
another course of tamoxifen treatment from 1 day before MI to 5 days
after MI. Echocardiography was performed in M-mode using a Toshiba
Aplio SSA-770a ultrasound system and a 12-MHz transducer as previ
ously described [24]. For pain management related to surgical proced
ures, mice were given a dose of Carprofen (5 mg/kg body weight) by
subcutaneous injection before the surgery followed by a second dose 12
h after the surgery. Mice were checked every day after MI for survival
rate. Mice found dead were subjected to necropsy to identify cardiac
rupture. Mice were euthanized by isoflurane overdose followed by cer
vical dislocation before sample collections.
2.3. Antibodies and biologics
Antibodies used in this study are listed in Table 2.EdU (sc-284628A)
was purchased from Santa Cruz Biotechnology Inc. Collagenase D
(11088866001) and Dispase II (4942078001) were purchased from
Roche Diagnostics. Collagen, type I (356236) was purchased from
Corning. TGF-β (240-B) was purchased from R&D Systems.
2.4. EdU in vivo fibroblast proliferation assay
Mice were treated with EdU at a dosage of 50 mg/kg body weight
through i.p. injections. Four hours after EdU injections, mice were
sacrificed, and heart samples were collected. EdU detection was carried
out after IHC staining using the Click-iT Plus Alexa Fluor 647 Picolyl
Azide Toolkit (C10643) from Thermo Fisher Scientific.
2.5. Cell isolation and culture
Cardiac fibroblasts were isolated as previously described [4]. Briefly,
heart tissue was minced and digested in DMEM containing 0.75 U/ml
collagenase D (Roche, 11,088,866,001), 1.0 U/ml Dispase II (Roche,
10,165,859,001), and 1 mM CaCl2 at 37 ◦ C for 40 min. The slurry was
then passed through a 100 μm cell strainer and then a 40 μm cell
strainer. Cells were collected by centrifugation at 350g for 10 min. The
cell pellets were resuspended in a growth medium composed of DMEM
with 10% bovine growth serum (BGS) and 1% of an antibiotic mixture
containing 10,000 U/ml penicillin, 10 mg/ml streptomycin, and 25 μg/
ml amphotericin B and seeded on cell culture plates. To induce Acta2
deletion, WT and Acta2fl/fl cardiac fibroblasts were treated with ade
noviruses expressing Cre (Adeno-Cre) at 60–80 multiplicity of infection
(MOI). Myofibroblast differentiation was induced by TGFβ (10 ng/ml)
treatment for 2 days. For Mrtfa knock down (KD) experiments, cardiac
fibroblasts were treated with lentiviruses expressing shRNA targeting
mouse Mrtfa (Lenti-shMrtfa) or control lentiviruses expressing GFP
(Lenti-GFP) at 20 MOI.

2. Materials and methods
2.1. Mice
Mouse embryonic stem cells with a “knockout-first” Acta2 allele
purchased from European Mouse Mutant Cell Repository were used to
generate chimeric mice. Chimeric mice were crossed with WT C57BL/6
mice to obtain offspring carrying the mutant allele which was then
crossed with mice expressing FLPe recombinase (Jackson Laboratory,
#003946) to delete the LacZ-neo cassette upstream of exon 5 of Acta2 to
generate Acta2fll+ mice with exons 5 to 7 of Acta2 flanked by loxP sites.
Tcf21MCM/+ [21] and R26eGFP [22] mice were crossed to generate
Tcf21MCM/+;R26eGFP mice. Acta2fll+ mice were crossed with Tcf21MCM/+;
R26eGFP mice to generate Tcf21MCM/+;Acta2fl/fl;R26eGFP mice. R26tdTomato
mice were purchased from Jackson Laboratory (#007914). The geno
typing for the Acta2fl allele was done using primers targeting the region
around 3’ loxP site (Table 1). Experiments include both males and
females.

2.6. Adenoviral and lentiviral particle production
Adeno-Cre were produced and purified as previously published
[25–27]. To produce Lenti-shMrtfa and Lenti-GFP, HEK293T cells were
co-transfected with psPAX2, pMD2.G, and pLKO.1 carrying shRNA tar
geting Mrtfa (Sigma #TRCN0000095961) or pLKO.1-puro-CMVTurboGFP (Sigma # SHC003). Lentiviral particles were purified as
previously described [28].

2.2. Animal procedures
To induce the activity of the MerCreMer protein, mice were treated
with tamoxifen (MilliporeSigma, T5648) dissolved in corn oil through i.
p. injections or gavage at a dosage of 75 mg/kg body weight/day for 5
days starting at 6 weeks of age. Mice were subjected to permanent
surgical ligation of the left coronary artery to induce MI at 9 weeks of

2.7. Gel contraction assay
Gel contraction assay was performed as previously described with
some modifications [26]. Briefly, cardiac fibroblasts transduced with
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Table 2
Antibody and other staining reagent list.
Source

Primary antibodies
Chicken anti-GFP
antibody
Rabbit anti-GFP
antibody
Mouse anti-SMαA
antibody
Rabbit anti-Ki67
antibody
Goat anti-Pdgfrα
antibody
Mouse antiβ-tubulin
antibody
Mouse anti-panactin antibody
Mouse anti-CyβA
antibody
Mouse antisarcomeric actin
(SkMαA and
CMαA) antibody
Mouse antismooth muscle
actin (SMαA and
SMγA) antibody
Mouse antivinculin
antibody
Mouse anti-CyγA
antibody
Secondary antibodies
Goat anti-Mouse
IgG2a CrossAdsorbed
Secondary
Antibody, Alexa
Fluor 488
Goat anti-Mouse
IgG2b CrossAdsorbed
Secondary
Antibody, Alexa
Fluor 488
IgG2b CrossAdsorbed Goat
anti-Mouse,
Alexa Fluor™
647
Goat anti-Mouse
IgM (Heavy
chain) CrossAdsorbed
Secondary
Antibody, Alexa
Fluor 488
Goat anti-Mouse
IgG2a CrossAdsorbed
Secondary
Antibody, Alexa
Fluor 555
Goat anti-Mouse
IgG1 CrossAdsorbed
Secondary
Antibody, Alexa
Fluor 555
Goat anti-Rabbit
IgG (H + L)
Cross-Adsorbed

Table 2 (continued )
Catalog #

Dilution
in IHC/
ICC

Dilution
in WB

Abcam

ab61682

1:100

Rockland

1:100
1:100

Cell Signaling
Technology
Novus

600–401215 L
113,200500UL
9129S
AF1062

1:100

DSHB

E7

DSHB

JLA20

1:50

1:200

Invitrogen

AM4302

1:200

1:1000

Millipore Sigma

A2172

1:100

Millipore Sigma

A7607

1:100

NOVUS

NB600–1293

1:100

Millipore Sigma

MABT824

1:200

1:1000

Invitrogen

A-21131

1:500

1:2000

Invitrogen

A-21141

1:500

1:2000

Millipore Sigma

Secondary
Antibody, Alexa
Fluor 555
Goat anti-Mouse
IgG (H + L)
Cross-Adsorbed
Secondary
Antibody, Alexa
Fluor 647

1:1000

1:200

Others
Alexa Fluor® 647
Phalloidin
#8940
Click-&-Go Plus
EdU 647 Cell
Proliferation
Assay Kits
Click-iT™ Plus
EdU Alexa
Fluor™ 647
Flow Cytometry
Assay Kit
Donkey antiMouse IgG (H +
L) Highly CrossAdsorbed
Secondary
Antibody, Alexa
Fluor™ 647
Donkey AntiRabbit IgG (H +
L), Alexa Fluor®
488
Donkey anti-Goat
IgG (H + L)
Cross-Adsorbed
Secondary
Antibody, Alexa
Fluor™ 555

1:300

Invitrogen

A21242

1:500

1:2000

Invitrogen

A-21042

1:500

1:2000

Source

Catalog #

Dilution
in IHC/
ICC

Dilution
in WB

Invitrogen

A-21235

1:500

1:2000

Cell Signaling
Technology

8940S

1:20

Click Chemistry
Tools

1353

Invitrogen

C10643 A

Invitrogen

A31571

1:500

1:2000

Jackson
ImmunoResearch

711–547003

1:500

1:2000

Invitrogen

A21432

1:500

1:2000

Adeno-Cre were treated with TGFβ (10 ng/ml) for 2 days to induced
myofibroblast differentiation. 60,000 treated cells were resuspended in
0.4 ml of growth medium and mixed with 0.2 ml of collagen solution (3
mg/ml) that contains 0.1% acetic acid. 4 μl of 1 M NaOH was added to
neutralize the acetic acid. 0.5 ml of the mixture was added to each well
of 24 well plates and allowed to solidify at room temperature for 20 min,
followed by the addition of 0.6 ml of growth medium supplemented with
TGFβ. 12 h after the incubation at 37 ◦ C, gels were carefully released
from the well to allow the contraction.
2.8. Rheology

Invitrogen

A-21137

1:500

1:2000

Invitrogen

A-21127

1:500

1:2000

Cell-free and cell-laden collagen gels were made and cultured as
described above. After 24 h of incubation, collagen gels were released
and trimmed using a 5 mm biopsy punch. Using a TA Discovery HR-2
rheometer and a 5 mm crosshatched plate, the storage moduli of gels
were determined by frequency sweeping from 6.28 to 25.13 (rad/s) at
2% strain and 10% compression.
2.9. Cell motility assay

Invitrogen

A-21428

1:500

Cell motility assay was performed using Oris Cell Migration Assem
bly Kit (Platypus Technologies) following the manufacturer’s protocol
with some modifications. Briefly, R26tdTomato and Acta2fl/fl;R26eGFP car
diac fibroblasts transduced with Adeno-Cre were treated with TGFβ (10
ng/ml) for 2 days to induce myofibroblast differentiation. Treated cells

1:2000
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of the 2 groups were mixed at a 1:1 ratio. A total of 20,000 cells in a
maintenance medium containing DMEM with 0.5% BGS and 1% of the
antibiotic mixture were seeded into each well of 96 well plates with a
stopper placed in the center of the well. The stoppers were removed
overnight and then the wells were gently washed with PBS, followed by
the addition of a fresh maintenance medium with or without TGFβ. For
the 3D migration test, after the rinse, 0.5 ml neutralized collagen solu
tion (3 mg/ml) was added to each well and allowed to solidify for 20 min
before adding a fresh maintenance medium with or without TGFβ. The
migration of cells into the center of the well was monitored using an
Echo Revolve microscope. Cells in the area previously occupied by the
stoppers were quantified and used to calculate the ratio between WT and
Acta2-null cardiac myofibroblasts. Images randomly taken in the areas
with attached cells were used to verify the 1:1 initial ratio before
removing the stoppers.

2.14. Immunocytochemical staining (ICC)
Cells grown on multiple-chamber slides or multiple well plates were
fixed in 4% paraformaldehyde (PFA) for 10 min, rinsed 3 times in TBS
with 0.1% Triton X-100, incubated in blocking buffer (TBS, 0.1% Triton
X-100, and 3% BSA) for 2 h at room temperature, and then incubated
with primary antibodies diluted in blocking buffer overnight at 4 ◦ C.
Cells were then rinsed in TBS with 0.1% Triton X-100 3 times and
stained with corresponding secondary antibodies diluted in blocking
buffer for 1 h at room temperature. Stained slides were then rinsed and
mounted in a mounting medium containing Dapi (Vector Laboratories).
Images were captured using an Echo Revolve microscope. Signal in
tensity was determined using ImageJ. The signal intensity of each image
was normalized to the number of cells indicated by Dapi staining.
2.15. Immunohistochemical staining (IHC)

2.10. Relative proliferation assay

2.11. FACS

IHC staining was performed as previously described [4]. Briefly,
mouse heart samples were fixed in 4% PFA, incubated in 30% sucrose
dissolved in PBS, and embedded in OCT (Tissue-Tek) for cryosectioning.
Cryosections (5 μm thick) were blocked with 5% goat serum and 0.2%
Triton X-100 diluted in TBS, incubated in primary antibodies diluted in
blocking buffer overnight at 4 ◦ C, and then incubated in appropriate
fluorophore-conjugated secondary antibodies diluted in blocking buffer
for 1 h at room temperature. Stained sections were then mounted in a
mounting medium containing Dapi (Vector Laboratories). Images were
captured using a Leica SP8X confocal microscope.

After tissue digestion, Tcf21 lineage-traced eGFP+ cardiac fibroblasts
were sorted on a FACSaria II flow cytometer (BD Biosciences).

2.16. Trichrome staining

R26tdTomato and Acta2fl/fl;R26eGFP cardiac fibroblasts were treated
with Adeno-Cre and TGFβ as described in the cell motility assay. Treated
cells of the 2 genotypes were mixed at a 1:1 ratio. A total of 25,000 cells
were seeded into each well of 24 well plates and cultured in a growth
medium with 10% BGS and 10 ng/ml TGFβ. Images captured after 2
days of incubation were used for quantification to calculate the relative
abundance of cells of the 2 genotypes.

Trichrome staining was performed using reagents for Masson’s Tri
chrome for Connective Tissue (Electron Microscopy Sciences) following
the manufacturer’s protocol. Percentage of the fibrotic area in the left
ventricle and average left ventricle thickness at 3 different segments
were determined using ImageJ.

2.12. Realtime PCR
Realtime PCR was performed as previously described [29]. Briefly,
RNA was extracted using a Direct-zol RNA Microprep Kit (Zymo). cDNA
synthesis of RNA was performed using an iScript cDNA Synthesis Kit
(Bio-Rad). Realtime PCR was carried out using a CFX RT-PCR detection
system (Bio-Rad) with SsoAdvanced Universal SYBR Green Supermix
(Bio-Rad). Relative mRNA content was normalized to 18S rRNA content.
The primers used are listed in Table 1.

2.17. Picrosirius red staining
Picrosirius red staining was carried out as previously described [4].
Briefly, longitudinal heart sections were collected from frozen samples
and incubated in Bouin’s fixative (Electron Microscopy Sciences,
26,367–01) for 1 h at 55 ◦ C and then stained with picrosirius red
(Electron Microscopy Science, 26,357–02) for 1 h at room temperature.
Sections were subsequently dehydrated and cleared with xylene. Pic
tures were captured in bright-field mode or under polarized light to
capture the birefringence of collagen fibers using a Leica light micro
scope. ImageJ was used to analyze the birefringence images to quantify
the signal intensities of type I collagen (yellow-red) and type III collagen
(green) and their ratio.

2.13. Western blot
Western blot was performed as previously described [30] with some
modifications. Briefly, cells were lysed in RIPA buffer with Halt Protease
Inhibitor Cocktail (Thermo Scientific) to extract the protein. SDS-PAGE
and blotting were performed using Bio-Rad Mini-PROTEAN Electro
phoresis System. After the immunostaining, images were taken using a
ProteinSimple FluorChem R System. Band density was normalized to
β-tubulin content.
Table 1
Primer sequences used in realtime PCR.
Target gene

Forward primer

Reverse primer

Actg2
Actg1
Actb
Acta1
Acta2
Actc1
Col1a1
Col3a1
Postn
18S
Mrtfa
Acta2 (genotyping)

GACTTCTCACACCCTTGGTGCTC
TGAGCAAGAAATGGCTACTGCTG
TCCTTCTTGGGTATGGAATCCTGT
AAGCCTCACTTCCTACCCTCGG
AAGAGCTACGAACTGCCTGACG
TATAAAGCTGCGCTCCAGGCGA
ACTCTGACTGGAAGAGCGGAGAG
GACCTAAGGGCGAAGATGGCAAA
ACAGGAGGTGGAGAAACAGGAGA
GTAACCCGTTGAACCCCATT
AAAATGGCTCCTCCAGTCAGCAC
AGTAGGGATGGTGTCACATTTCCA

AAGGGCGGTGGTCTCTTCTTCAC
ACAGGACTCCATGCCCAGGAA
TTTACGGATGTCAACGTCACACTTC
AGAGCCGTTGTCACACACAAGAG
GTTTCGTGGATGCCCGCTGA
CTTTGGTGGGTTCTGTAGGCGTG
GCTGAGTAGGGAACACACAGGTC
GGAAGCCACTAGGACCCCTTTCT
CCTTGAACCCTTTTGTTGGCTGG
CCATCCAATCGGTAGTAGCG
TGGTAGGGATGGTGGCTCTTTGA
CTCTCAGCACTCAGATCGTCTTCC
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2.18. RNAseq

2.22. Study approval

RNAseq was performed as previously described [31]. Briefly, cardiac
fibroblasts isolated from WT and Acta2fl/fl mice were transduced with
Adeno-Cre, treated with TGFβ for 2 days, and then subjected to RNA
isolation using a Direct-zol RNA Microprep Kit (Zymo). cDNA libraries
were constructed using the NEBNext single cell/low input RNA library
prep kit for Illumina (E6420) from New England BioLabs. The cDNA
libraries were sequenced on the Illumina Hi-seq platform using 150 bp
paired-end sequencing. RNA-seq reads that passed filters were trimmed
to remove low-quality reads and adaptors by TrimGalore-0.6. The
quality of reads after filtering was assessed by fastQC, followed by
alignment to the mouse genome (MM10) by STAR (2.5.3a) with default
parameters. Individual mapped reads were adjusted to provide TPM
(transcripts per million) values with mouse genome as the reference.

All experiments involving mice were approved by the IACUC at LSU
(approval numbers IACUC 18–024 and 21–034).
3. Results
3.1. Cardiac fibroblast-specific deletion of Acta2 does not affect post-MI
survival, cardiac function, or remodeling
To generate a mouse line with cardiac fibroblast-specific tamoxifeninducible Acta2 deletion, mice with Acta2 exons 5–7 flanked by loxP
sites (Acta2fl/fl) were crossed with Tcf21-MerCreMer (Tcf21MCM/+) mice
that also carry a Cre-dependent eGFP cassette in the Rosa26 locus
(R26eGFP) (Fig. 1A). In these mice (Tcf21MCM/+;Acta2fl/fl;R26eGFP), the
deletion of Acta2 exons 5–7 and expression of eGFP in Tcf21-lineage
traced cardiac fibroblasts can be induced by tamoxifen treatment.
Tcf21MCM/+;Acta2fl/fl;R26eGFP and Tcf21MCM/+;R26eGFP (WT control)
mice were treated with tamoxifen for 5 days to induce Cre activity
starting at 6 weeks of age and then subjected to surgeries to induce MI at
9 weeks of age (Fig. 1B). To maximize the efficiency of Acta2 deletion
and reduce the negative effect of prolonged continuous tamoxifen
treatment on the viability of mice, another course of tamoxifen treat
ment was applied to mice from 1 day before MI to 5 days after MI. No
significant difference in the post-MI survival rate between Tcf21MCM/+;
Acta2fl/fl;R26eGFP and Tcf21MCM/+;R26eGFP mice was observed (Fig. 1C).
Moreover, the cardiac function of the two groups was not significantly
different from each other without injury and on days 7 and 28 after MI
(Figures 1DE). To study the potential impact of Acta2 deletion on the
post-MI cardiac repair and remodeling, heart samples were collected
from Tcf21MCM/+;Acta2fl/fl;R26eGFP and Tcf21MCM/+;R26eGFP mice on
days 7 and 28 after MI and subjected to IHC for type I collagen, tri
chrome staining, and picrosirius red staining. No difference in the his
tology and fibrotic response of the heart was observed between
Tcf21MCM/+;Acta2fl/fl;R26eGFP and Tcf21MCM/+;R26eGFP mice (Figs. 1F-J),
suggesting relatively normal tissue remodeling in Tcf21MCM/+;Acta2fl/fl;
R26eGFP mice after MI. The infiltration of Tcf21-lineage traced cardiac
fibroblasts into the infarct scar was also not affected by the loss of Acta2
(Fig. 1F), suggesting that the motility of cardiac fibroblasts is not
affected by the lack of SMαA stress fibers. Together, these results suggest
that the loss of SMαA in cardiac myofibroblasts does not affect post-MI
cardiac repair or tissue remodeling.

2.19. ATACseq
ATACseq was performed as previously described [31]. Briefly, car
diac fibroblasts isolated from WT and Acta2fl/fl mice were transduced
with Adeno-Cre, treated with TGFβ for 2 days, and then 10,000 cells
were lysed on ice for 20 min to isolate the nuclei. Isolated nuclei were
then incubated with the Tn5 transposase (TDE1, Illumina) and tag
mentation buffer at 37 ◦ C for 30 min with shaking on a thermomixer at
700 rpm. Tagmentated DNA was purified using MinElute Reaction
Cleanup Kit (Qiagen). PCR was performed to amplify the ATACseq li
braries using Illumina TrueSeq primers and multiplex by indexes
primers. After the PCR reaction, libraries were purified with the 1.1×
AMPure beads (Beckman). The ATACseq libraries were sequenced on
the Illumina Hi-seq platform using 150 bp paired-end sequencing.
Sequencing reads of all samples underwent adapter removal using
TrimGalore-0.6, followed by quality assessment using FastQC. Reads
were then aligned to the mouse reference genome MM10 using Bowtie
2.3 with the following options: – very-sensitive -X 2000 – no-mixed – nodiscordant. Only unique alignments within each sample were retained in
subsequent analysis. Moreover, alignments resulting from PCR dupli
cates or located in mitochondria were excluded. The mouse genome was
tiled with consecutive non-overlapping 300 bp bins. The accessibility of
each of the 300 bp bins was assessed by the number of fragments per
million mapped (FPM) that was aligned to the bin. ATAC-seq peaks were
called separately for each sample by MACS2 [32] with the following
options: – keep-dup all – nolambda – nomodel. The identification of
transcriptional factor motifs in peaks was evaluated using HOMER (http:
//homer.ucsd.edu/homer/motif/).

3.2. Cardiac fibroblast-specific deletion of Acta2 does not affect the
expansion of cardiac fibroblasts in the infarct after MI or their
proliferation in vitro

2.20. Statistics

It was reported that global Acta2 KO led to increased renal fibroblast
expansion [18]. To study if specific deletion of Acta2 in cardiac fibro
blasts also affects their post-MI expansion, a 5-Ethynyl-2′ -deoxyuridine
(EdU)-based in vivo proliferation assay was performed. Using this
method, we previously identified that the proliferation of cardiac fi
broblasts after MI peaked at day 3 after MI and was largely diminished
beyond day 7 post-MI [4]. Thus, a single EdU injection was given to mice
on days 3 or 7 after MI, followed by sample collection 4 h after the EdU
injection. Efficient Acta2 deletion in Tcf21 lineage-traced cardiac fi
broblasts of Tcf21MCM/+;Acta2fl/fl;R26eGFP mice was observed, indicated
by the absence of SMαA expression in GFP+ cardiac fibroblasts
(Fig. 2AB). However, in these mice, the expression of SMαA in vascular
smooth muscle cells and non-Tcf21 lineage-traced cardiac fibroblasts
was not affected, showing the fidelity of our cell type-specific KO system
(Fig. S1). EdU and Ki67 staining showed that the post-MI proliferation
of Tcf21-lineage traced cardiac fibroblasts was not different between
Tcf21MCM/+;Acta2fl/fl;R26eGFP and Tcf21MCM/+;R26eGFP mice (Fig. 2AB).
To verify these findings in vitro, cardiac fibroblasts were isolated from
Acta2fl/fl and WT mice, treated with Adeno-Cre, and induced for

All data are expressed as mean ± SEM unless otherwise stated. Data
were analyzed using GraphPad Prism 9 (GraphPad Software, Inc.). Twotailed t-test was used to determine the significance of differences be
tween the 2 groups. One-way ANOVA with post hoc Tukey’s test was
used to determine the significance of difference when >2 groups were
compared. Gehan–Breslow–Wilcoxon test was used to determine the
significance of difference between the survival rates of Tcf21MCM/+;
R26eGFP and Tcf21MCM/+;Acta2fl/fl;R26eGFP mice. All data are shown as
mean with SEM. P < 0.05 was considered significant.
2.21. Data availability
RNAseq data of cardiac fibroblasts isolated from uninjured hearts
and infarct scars were from our previous study [31] (GEO
#GSE186079). All new raw sequencing data have been deposited into
the public database at NCBI (GEO #GSE193163).
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Fig. 1. Cardiac fibroblast-specific deletion of Acta2 does not affect the post-MI survival or cardiac function of mice.
(A) Schematic of the generation of Tcf21MCM/+;Acta2fl/fl;R26eGFP mice. In these mice, a tamoxifen-regulated MerCreMer cDNA cassette inserted into exon 1 (E1) enables the tamoxifen-induced deletion of the loxP siteflanked stop cassette upstream of eGFP inserted into the R26 locus and the deletion of the loxP site-flanked exons 5–7 (E5–7) of Acta2 only in cells expressing Tcf21. (B) Experimental scheme of tamoxifen treatment and
surgical procedure to induce MI. (C) Survival curves showing the survival rate of Tcf21MCM/+;R26eGFP and Tcf21MCM/+;Acta2fl/fl;R26eGFP mice after MI. n = 135 (Tcf21MCM/+;R26eGFP); n = 110 (Tcf21MCM/+;Acta2fl/fl;
R26eGFP). (D-E) Fraction shortening (D) and ejection fraction (E) of Tcf21MCM/+;R26eGFP and Tcf21MCM/+;Acta2fl/fl;R26eGFP mice without MI and at 7 and 28 days after MI. n = 9 for uninjured mice; n = 13 for Tcf21MCM/+;
R26eGFP mice at 7 and 28 days after MI; n = 12 for for Tcf21MCM/+;Acta2fl/fl;R26eGFP mice 7 days after MI; n = 9 for Tcf21MCM/+;Acta2fl/fl;R26eGFP mice 28 days after MI. (F–I) Heart samples were collected from
tamoxifen-treated Tcf21MCM/+;R26eGFP and Tcf21MCM/+;Acta2fl/fl;R26eGFP mice at 7 and 28 days after MI. (F) Representative IHC images from 5 analyzed hearts per group show the presence of eGFP+ Tcf21 lineage-traced
cardiac fibroblasts and the expression of type I collagen (Col1). Nuclei are shown with Dapi. Scale bar: 50 μm. (G) Representative trichrome staining images from 5 analyzed hearts per group showing the dilation of the
left ventricle after MI and collagen deposition in the infarct area. Scale bar: 1 mm. (H–I) Percentage of the fibrotic area in the left ventricle (H) and average left ventricle thickness (I) determined by analysis of trichrome
staining images using ImageJ. n = 5 for each group. (J) Representative picrosirius red staining images from 6 analyzed hearts per group showing the collagen maturation (type I/III collagen ratio) in the infarct area. n =
6. Scale bar: 50 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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Fig. 2. Cardiac fibroblast-specific deletion of Acta2 does not alter cardiac fibroblast proliferation after MI.
(A-B) Tamoxifen-treated Tcf21MCM/+;R26eGFP and Tcf21MCM/+;Acta2fl/fl;R26eGFP mice were subjected to MI and EdU based proliferation assays at 3 days and 7 days
post-MI. IHC was performed to identify and quantify Tcf21 lineage-traced (eGFP+) cardiac fibroblasts that are positive for SMαA, Ki67, or EdU in the infarct region at
3 days (A) and 7 days (B) after MI. n = 3 for each group. Scale bar: 20 μm. (C) ICC was performed to identify the expression of SMαA and Ki67 in WT and Acta2-null
cardiac myofibroblasts. Nuclei are shown with Dapi. n = 4 for each group. Scale bar: 100 μm. (D) Cardiac fibroblasts isolated from R26tdTomato (WT) and Acta2fl/fl;
R26eGFP mice were transduced with Adeno-Cre and co-cultured at a 1:1 ratio. The ratio between WT and Acta2-null cardiac fibroblasts was calculated again after 48 h
of co-culture in the presence of TGFβ. n = 3 for each group. Scale bar: 250 nm. **P < 0.01; ***P < 0.0001.
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myofibroblast differentiation by TGFβ treatment. No difference in the
percentage of cells expressing Ki67 was observed between the 2 groups
(Fig. 2C). A proliferation assay was also performed by co-culturing
TGFβ- and Adeno-Cre-treated cardiac fibroblasts isolated from Acta2fl/
fl
;R26eGFP mice and R26tdTomato mice (tdTomato is expressed in response
to Adeno-Cre) mixed at a 1:1 ratio. The ratio remained the same after 48
h of incubation, further suggesting that Acta2 deletion does not affect
the proliferation of cardiac fibroblasts (Fig. 2D).

myofibroblasts (Fig. 4A). To specifically study the effect of Acta2 dele
tion on the myofibroblast differentiation of Tcf21 lineage-traced cardiac
fibroblasts, cardiac fibroblasts were isolated from tamoxifen-treated
Tcf21MCM/+;Acta2fl/fl;R26eGFP and Tcf21MCM/+;R26eGFP mice and
cultured in a medium supplemented with TGFβ. ICC showed the lack of
SMαA expression in most Tcf21 lineage-traced cardiac myofibroblasts
from Tcf21MCM/+;Acta2fl/fl;R26eGFP mice but not in Tcf21 lineage-traced
cardiac myofibroblasts from Tcf21MCM/+;R26eGFP mice (Fig. 4B). How
ever, no significant difference was observed in the total F-actin level
between Tcf21 lineage-traced cardiac myofibroblasts of the 2 groups of
mice (Fig. 4B). Similarly, on day 7 after MI the amount of F-actin stress
fibers in Tcf21 lineage-traced cardiac fibroblasts in the infarct scar of
Tcf21MCM/+;Acta2fl/fl;R26eGFP mice was similar compared to that in
Tcf21MCM/+;R26eGFP mice (Fig. 4C). Stress fibers guide the maturation of
focal adhesion [38]. We then questioned if the lack of SMαA stress fiber
in cardiac fibroblasts had an effect on the formation of focal adhesion.
ICC using an anti-vinculin antibody showed that Acta2 deletion did not
significantly affect the abundance of mature focal adhesion (Fig. 4D).
These results suggest that the deletion of Acta2 in cardiac fibroblasts
does not prevent myofibroblast differentiation.

3.3. Cardiac myofibroblasts lacking Acta2 have normal motility,
contractility, and matrix stabilization ability
Besides the unaffected cardiac fibroblast proliferation, in vivo ex
periments using Tcf21MCM/+;R26eGFP and Tcf21MCM/+;Acta2fl/fl;R26eGFP
mice also suggest that the deletion of Acta2 in cardiac fibroblasts does
not affect their motility or contractility after MI (Figs. 1F-I). To verify
these results in more controlled environments, the effects of Acta2
deletion on the motility and contraction of cardiac myofibroblasts were
tested in vitro. For a direct comparison of motility, Adeno-Cre-treated
Acta2fl/fl;R26eGFP cardiac fibroblasts and R26tdTomato cardiac fibroblasts
co-cultured at 1:1 ratio were monitored for their migration toward the
center of the well. No difference was observed between the 2 groups in
the presence or absence of TGFβ (Fig. 3A). To better simulate the 3D
matrix environment in the infarct, the same experiment was repeated
with the addition of a layer of collagen gel cast on top of the cocultured
cardiac myofibroblasts, which however also failed to show any signifi
cant difference (Fig. 3A). To test the effect of Acta2 deletion on the
contractility of cardiac myofibroblasts, a gel contraction assay was
performed using cardiac fibroblasts isolated from Acta2fl/fl and WT mice
and treated with Adeno-Cre and TGFβ, which showed no difference
between the 2 groups (Fig. 3B). It has been shown that cells can function
as a crosslinker to strengthen the mechanical property of the matrix
[33], a possible mechanism through which cardiac fibroblasts/myofi
broblasts maintain the structural integrity of the infarct. Such a process
likely involves the connection between actin stress fibers and ECM
through focal adhesion. Thus, we employed rheology to test the impact
of Acta2 deletion on the effect of cardiac fibroblasts on the stability of
the collagen gel they reside in. In rheology, the storage modulus in
dicates the ability of the material to store deformation energy in an
elastic manner while maintaining structural integrity and has been used
to measure the strength of biomaterials [34–36]. Hydrogels with a
greater level of crosslinking have a higher storage modulus [37]. Cardiac
fibroblasts isolated from Acta2fl/fl and WT mice were treated with
Adeno-Cre and TGFβ, mixed with collagen gel, and cultured for 24 h to
allow for the development of tension, followed by tests using a rheom
eter. The presence of cardiac fibroblasts increased the storage modulus
of collagen gels (Fig. 3C). However, no significant difference was
observed in the storage modulus between collagen gels laden with WT
myofibroblasts and those laden with Acta2-null myofibroblasts. This
suggests that the loss of Acta2 does not affect the matrix stabilization
capacity of myofibroblasts, which is in line with the similar post-MI
survival rates between Tcf21MCM/+;R26eGFP and Tcf21MCM/+;Acta2fl/fl;
R26eGFP mice.

3.5. Compensatory effects of non-SMαA actin isoforms in Acta2-null
cardiac myofibroblasts
Besides Acta2/SMαA, 5 other actin isoforms are also expressed in
mice, including Acta1 (skeletal muscle alpha-actin, SkMαA), Actb
(cytoplasmic beta-actin, CyβA), Actc1 (cardiac muscle alpha-actin,
CMαA), Actg1 (cytoplasmic gamma-actin, CyγA), and Actg2 (smooth
muscle gamma-actin, SMγA). To study the impact of Acta2 deletion on
the total actin level in cardiac fibroblasts, Acta2fl/fl and WT cardiac fi
broblasts treated with Adeno-Cre and induced for myofibroblast differ
entiation were subjected to western blot and ICC using a pan-actin
antibody that recognizes all actin isoforms (Fig. 4EF). It was found that
the deletion of Acta2 did not affect the total actin protein level in cardiac
myofibroblasts. The unaffected F-actin and total actin levels in Acta2null cardiac fibroblasts suggest some compensatory effects mediated by
other actin isoforms. To explore this possibility, we first examined the
relative expression levels of different actin isoforms in cardiac fibro
blasts after MI using our recently published RNAseq data obtained using
Tcf21 lineage-traced cardiac fibroblasts isolated from uninjured hearts
and infarct scars at different days after MI [31]. The result showed that
even though Acta2 was the most upregulated actin isoform in cardiac
fibroblasts after MI by fold change, the expression of Actb, Actg1, and
Actg2 were also upregulated (Fig. 5A). Moreover, in cardiac myofibro
blasts, Actg1 was expressed at a level comparable to Acta2 and the
expression level of Actb was about 2.5 folds of that of Acta2 (Fig. 5A).
Adeno-Cre- and TGFβ-treated WT and Acta2fl/fl cardiac fibroblasts were
then compared to study the impact of Acta2 KO on the expression of
other actin isoforms by realtime PCR. A unique upregulation in the
expression of Acta1 and Actg2 was identified in Acta2-null cardiac
myofibroblasts as compared to the WT control (Fig. S2). RNAseq was
also performed so that the expression level between different actin iso
forms can be compared as well. Consistent with results of realtime PCR,
RNAseq identified significant compensatory increases in the expression
of Acta1 and Actg2 in Acta2-null cardiac fibroblasts (Fig. 5B). Interest
ingly, a slight but significant increase in the expression of Actb and Actg1
was also observed (Fig. 5B). A similar small increase in the expression of
Actc1 was identified as well, however, the difference was not significant
due to its extremely low expression and high in-group variance (Fig. 5B).
Moreover, similar to RNAseq performed using WT fibroblasts isolated
from infarct scars, the expression of cytoplasmic actin isoforms, Actb and
Actg1, were several folds higher than that of Acta2 (Fig. 5B). Consis
tently, Tcf21 lineage-traced cardiac fibroblasts sorted from the infarct
scar of Tcf21MCM/+;Acta2fl/fl;R26eGFP mice at post-MI day 7 showed
increased expression of Actg1 and Actg2, and a trend of increase in the
expression of Acta1 compared to cells from Tcf21MCM/+;R26eGFP mice

3.4. Acta2 deletion in cardiac fibroblasts does not prevent myofibroblast
differentiation
Studies using global Acta2 KO mice showed that the deletion of Acta2
did not seem to prevent the formation of filamentous actin (F-actin)
stress fiber in myofibroblasts derived from fibroblasts of several
different organs [18–20]. To test if this was also the case in cardiac fi
broblasts, cardiac fibroblasts were isolated from Acta2fl/fl and WT mice,
treated with Adeno-Cre, and induced for myofibroblast differentiation
using TGFβ. ICC using an antibody against SMαA combined with phal
loidin staining showed that the amount of F-actin stress fibers was not
significantly different between WT and Acta2-null cardiac
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Fig. 3. Deletion of Acta2 does not affect the motility, contractility, and matrix stabilization ability of cardiac fibroblasts.
(A) WT (tdTomato+) and Acta2-null (GFP+) cardiac myofibroblasts were seeded onto the same wells of 96-well plates at a 1:1 ratio. The migration of cells into the
center of wells was quantified every day. n = 3 for each group. Scale bar: 300 μm. (B–C) WT and Acta2-null cardiac myofibroblasts were mixed with collagen gel and
poured onto 24 well plates. (B) Gels were released from wells after 12 h of incubation. Images and quantification show the degree of contraction of gels 48 h after the
release of gels. n = 3 for each group. (C) The storage moduli of cell-free gels and cell-laden gels 24 h after incubation were measured using a rheometer. n = 5 for
each group.

(Fig. 5C). The expression of Actc1 was undetectable due to its extremely
low expression. To understand the effect of Acta2 deletion on the protein
level of other actin isoforms, we performed ICC using antibodies against
different actin isoforms. Staining with an antibody recognizing smooth
muscle actin isoforms (SMαA and SMγA) showed that in WT cardiac
myofibroblasts the combined expression level of SMαA and SMγA was
largely correlated with the expression level of SMαA and the combined
protein level of SMαA and SMγA in Acta2-null cardiac myofibroblasts
was significantly lower than that in WT cardiac myofibroblasts, sug
gesting that SMαA is the dominant smooth muscle actin isoform in
cardiac myofibroblasts (Fig. 5DE). However, some Acta2-null cardiac
myofibroblasts (20.7% ± 2.8, n = 3) had a total smooth muscle actin
level similar to WT cardiac myofibroblasts, suggesting a strong
compensatory increase in the expression of SMγA in these cells (Fig. 5D).
It is worth noting that due to the lack of an antibody specific to SMγA, we
were unable to identify the exact percentage of cells with upregulated
SMγA expression. The actual percentage of Acta2-null cardiac myofi
broblasts with upregulated SMγA expression was likely much higher.
Co-staining using an antibody that recognizes sarcomeric actin isoforms
(SkMαA and CMαA) showed that the expression of sarcomeric actin in
most Acta2-null cardiac myofibroblasts (80.1% ± 6.4, n = 3) was higher
than that in WT cardiac myofibroblasts (Fig. 5DE). These findings are in
line with the realtime PCR and RNAseq results (Fig. 5BC). In addition,
we noticed that the strong compensatory increase in the expression of
SMγA and upregulated expression of sarcomeric actin isoforms only
coexisted in a small fraction of Acta2-null cardiac myofibroblasts (4.5%
± 0.75, n = 3) (Fig. 5D), which suggests that the adaption of cardiac
fibroblasts to the deletion of Acta2 varies among individual cells. We
then tested the effect of Acta2 deletion on the expression of cytoplasmic
actin isoforms in cardiac myofibroblasts. Western blot showed similar
expression levels for both CyβA and CyγA between WT and Acta2-null
cardiac myofibroblasts (Fig. 5F). However, ICC showed that the for
mation of F-actin by cytoplasmic actin isoforms, especially CyγA, was
enhanced in Acta2-null cardiac myofibroblasts as compared to WT car
diac myofibroblasts (Fig. 5G). These results suggest the existence of
compensatory effects mediated by multiple non-SMαA actin isoforms in
Acta2-null cardiac myofibroblasts.
Another major function of myofibroblasts is the secretion of ECM
proteins. The expression of Col1a1, Col3a1, and Postn in Tcf21 lineagetraced cardiac fibroblasts sorted from infarct scars of Tcf21MCM/+;
R26eGFP and Tcf21MCM/+;Acta2fl/fl;R26eGFP mice at post-MI day 7 were
measured. No difference in Col1a1 and Col3a1 expression was identified
(Fig. 5C), which agreed with the picrosirius red staining data (Fig. 1J).
However, slightly lower expression of Postn was identified in cells from
Tcf21MCM/+;Acta2fl/fl;R26eGFP mice.

downstream of Actg2 and adjacent to an SRF motif in Acta2-null cardiac
myofibroblasts as compared to WT cardiac myofibroblasts (Fig. S3B).
These results suggest that SRF/MRTFA may regulate the expression of
muscle actin isoforms and is involved in the compensatory increase in
the expression of non-Acta2 actin isoforms in Acta2-null cardiac myo
fibroblasts. To test these possibilities, we knocked down Mrtfa in WT and
Acta2-null cardiac fibroblasts using Lenti-shMrtfa and then induced
myofibroblast differentiation. ICC showed that KD of Mrtfa significantly
reduced the expression of SMαA and the abundance of F-actin but had no
effect on the total actin level (Figs. 6A-C). Realtime PCR showed that
besides the reduced expression of Acta2, KD of Mrtfa also reduced the
expression of Acta1 and Actg2 but did not affect the expression of
cytoplasmic actin isoforms, Actb and Actg1 (Fig. 6D). Interestingly, an
increase in the expression of Actc1 was observed in Mrtfa KD cardiac
fibroblasts likely due to a compensatory increase induced by the
downregulated expression of all other muscle actin isoforms (Fig. 6D).
Surprisingly, despite the reduced expression of Actg2 and Acta1, Mrtfa
KD did not affect the compensatory increase in the expression of these
actin isoforms caused by Acta2 KO (Fig. 6D). Moreover, a slight increase
in the expression of Actg1 was observed in Mrtfa KD Acta2-null cardiac
myofibroblasts likely due to a compensatory effect induced by the
seriously disrupted expression of muscle actin isoforms by Acta2 KO and
Mrtfa KD (Fig. 6D). ICC performed using antibodies against specific actin
isoforms largely agreed with realtime PCR results, showing that Mrtfa
KD reduced the expression of muscle actin isoforms but did not affect the
expression of cytoplasmic actin isoforms or the compensatory increase
in the expression of sarcomeric actin isoforms (Figs. 6E-G).
4. Discussion
Myofibroblasts with a highly developed microfilament system were
first identified in skin wounds [41]. Later studies found that these cells
express an elevated level of SMαA which is incorporated into stress fi
bers [42–44]. Ever since, SMαA stress fiber has been used as a marker for
myofibroblast differentiation. Due to the specific expression of SMαA in
myofibroblasts, it was speculated that SMαA stress fiber may play an
important role in multiple myofibroblast activities involved in wound
healing such as contraction, motility, and myofibroblast proliferation.
However, in this study, using a newly generated mouse line with
tamoxifen-inducible cardiac fibroblast-specific deletion of Acta2, we
identified that the loss of Acta2 did not significantly affect the myofi
broblast differentiation of cardiac fibroblasts. No difference in contrac
tility, matrix stabilization ability, proliferation, or motility was observed
between WT and Acta2-null cardiac myofibroblasts. In line with results
obtained in vitro, mice lacking Acta2 in cardiac fibroblasts also had
normal post-MI survival rate, cardiac repair, and cardiac function. The
unaffected myofibroblast differentiation of Acta2-null cardiac fibro
blasts was likely due to the increased expression or stress fiber formation
of non-SkMαA actin isoforms.
Due to the contractile function of vascular smooth muscle cells,
which also express a high level of SMαA, it is reasonably expected that
SMαA is required for the contraction of myofibroblasts. In infarcted
hearts, the tonic contraction of cardiac myofibroblasts is thought to
negatively affect cardiomyocyte contraction [45,46]. However, the
tonic contraction of stress fibers in cardiac myofibroblasts may also
stabilize the infarcted myocardium through cross-linking the sur
rounding matrix in cooperation with focal adhesion [15,33,38], which
may be especially important before the scar ECM is mature enough to

3.6. The compensatory increase in the expression of other muscle actin
isoforms in Acta2-null cardiac myofibroblasts does not require SRF/
MRTFA
Serum response factor (SRF) and its cofactor, myocardin-related
transcription factor-A (MRTFA), promote myofibroblast differentiation
and stress fiber formation [39,40]. To explore the role of SRF/MRTFA in
the compensatory increase of the expression of other muscle actin iso
forms in Acta2-null cardiac myofibroblasts, we first performed ATACseq,
which identified SRF binding motifs in accessible chromatin regions in
and around Acta2, Actg2, and Acta1 (Figs. S3A-C; Table S1). Moreover,
increased accessibility was identified in a region immediately
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Fig. 4. Deletion of Acta2 does not prevent the myofibroblast differentiation of cardiac fibroblasts.
(A) WT and Acta2-null cardiac myofibroblasts were subjected to ICC to identify the expression of SMαA and presence of F-actin using an anti-SMαA antibody and phalloidin, respectively. Nuclei are shown with Dapi.
Scale bar: 100 μm. The fluorescence intensity was determined using ImageJ. n = 3 for each group. **P < 0.01. (B) Cardiac fibroblasts isolated from tamoxifen-treated Tcf21MCM/+;R26eGFP and Tcf21MCM/+;Acta2fl/fl;
R26eGFP mice were treated with TGFβ for 2 days and subjected to ICC to identify the expression of SMαA and presence of F-actin. Nuclei are shown with Dapi. Images represent 3 independent replications. Scale bar: 40
μm. (C) IHC was performed to identify Tcf21 lineage-traced (eGFP+) cardiac fibroblasts that are positive for SMαA or/and phalloidin in Tcf21MCM/+;R26eGFP and Tcf21MCM/+;Acta2fl/fl;R26eGFP mice at post-MI day 7.
Nuclei are shown with Dapi. Images represent 3 analyzed hearts per group. Scale bar: 20 μm. (D) WT and Acta2-null cardiac myofibroblasts were subjected to ICC to identify the expression of SMαA and vinculin using
specific antibodies. Nuclei are shown with Dapi. n = 4 for each group. Scale bar: 40 μm. The average area of focal adhesion was measured using ImageJ. (E-F) Western blot (E) and ICC (F) were performed to quantify
SMαA and total actin protein levels in WT and Acta2-null cardiac myofibroblasts using an anti-SMαA antibody and a pan-actin antibody, respectively. Scale bar: 100 μm. n = 3 (western blot) or n = 4 (ICC) for each
group; **P < 0.01.
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Fig. 5. The compensatory effects of non-SMαA actin isoforms in Acta2-null cardiac myofibroblasts.
(A) Tcf21 lineage-traced cardiac fibroblasts sorted from uninjured hearts and the infarct region at 3 days and 7 days after MI were subjected to RNAseq. The
normalized transcription levels (TPM) of Acta2, Acta1, Actb, Actc1, Actg1, and Actg2 are shown. n = 2 for each group. *P < 0.05; ***P < 0.0001 vs uninjured. (B) The
transcription levels of Acta2, Acta1, Actb, Actc1, Actg1, and Actg2 in cultured WT and Acta2-null cardiac myofibroblasts were revealed by RNAseq. n = 2 for each
group. **P < 0.01. (C) Tcf21 lineage-traced cardiac fibroblasts were sorted from the infarct scar of Tcf21MCM/+;R26eGFP and Tcf21MCM/+;Acta2fl/fl;R26eGFP mice at
post-MI day 7. The expression level of Acta2, Acta1, Actg1, Actg2, Col1a1, Col3a1, and Postn were revealed by realtime PCR. n = 4 for each group. *P < 0.05; **P <
0.01. (D-E) WT and Acta2-null cardiac myofibroblasts were subjected to ICC to identify the protein level of SMαA, the combined protein level of SkMαA and CMαA,
and the combined protein level of SMαA and SMγA using specific antibodies (D). Nuclei are shown with Dapi. Higher-magnification images highlight the areas
marked by solid-line boxes (colour-coded). Scale bar: 100 μm. The fluorescence intensity was measured using Image J (E). n = 3 for WT; n = 4 for Acta2-null. **P <
0.01; ***P < 0.0001. (F-G) Western blot (F) and ICC (G) were performed to quantify SMαA, CyβA, and CyγA protein levels in WT and Acta2-null cardiac myofi
broblasts using specific antibodies. Higher-magnification images highlight the areas marked by yellow solid-line boxes. n = 3 for each group (F). Images represent 3
independent replications (G). Scale bar: 100 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of
this article.)

prevent cardiac rupture. A similar role of myofibroblast contraction may
also present in other types of tissue after injury. Thus, the role of SMαA
in myofibroblast contraction has received some special attention. It was
found that overexpression of Acta2 increased the contractility of 3T3
fibroblasts more significantly than the overexpression of Actb, Actg1, or
Actc1, even though the incorporation of all actin isoforms into stress
fibers was identified [47]. Disruption of the SMαA stress fiber structure
using an SMαA fusion peptide containing the N-terminal of SMαA [48]
reduced adhesion and contractility of rat embryo fibroblast cell line
REF-52 [16]. Besides these early studies of the function of SMαA stress
fibers that were mainly performed in vitro using cell lines, the function of
SMαA stress fibers in primary myofibroblasts and their role during tissue
healing were recently studied by a few groups using whole-body Acta2
KO mice [18–20]. Deletion of Acta2 was reported to reduce the
contractility of hepatic stellate cells-derived myofibroblasts [20].
However, another study reported that mice lacking Acta2 had normal
skin wound closure and the contractility of skin fibroblasts isolated from
these mice was not different from those isolated from WT mice [19],
which is in line with the current study showing the lack of difference in
contractility between WT and Acta2-null cardiac myofibroblasts. The
unchanged myofibroblast contractility may also explain the unaffected
post-MI survival rate and cardiac remodeling in cardiac fibroblastspecific Acta2 KO mice.
Besides the contractile function of myofibroblasts, previous studies
have also investigated the effects of SMαA stress fibers on myofibroblast
motility, proliferation, and ECM production. A study inhibiting SMαA
function using a neutralization antibody identified that the motility of
breast tissue-derived myofibroblasts was enhanced when SMαA function
was inhibited [15]. Another study found that renal fibroblasts isolated
from Acta2-null mice had enhanced motility and proliferation in vitro
[18]. In addition, the same study also identified an elevated level of
collagen production by Acta2-null renal myofibroblasts, which exacer
bated renal fibrosis. In contrast, the deletion of Acta2 reduced the
collagen expression by myofibroblasts Acta2-null hepatic stellate cells
[20]. Our study, however, did not identify a significant change in any of
these myofibroblast functions and activities in cardiac myofibroblasts
owing to Acta2 deletion. Interestingly, we found that cardiac fibroblasts
from Tcf21MCM/+;Acta2fl/fl;R26eGFP mice expressed a slightly lower level
of Postn compared to cells from Tcf21MCM/+;R26eGFP mice after MI. Even
though the underlying mechanism remains to be studied, this slight
reduction in Postn expression did not seem to alter the overall post-MI
healing of the heart.
The reason for the large discrepancy among results generated by
different studies of the function of SMαA may be multifaceted. First, it is
well known that immortalized cell lines, which were used by many early
studies, often act significantly differently from primary cells. Second, the
experimental procedure of studies using SMαA fusion peptide and
neutralization antibodies often depend on the treatment-induced acute
effects that suddenly disrupt SMαA stress fiber function followed by
functional analyses. This strategy likely did not provide other actin
isoforms with enough time to develop a compensatory effect. Indeed,
even though Acta2-null mice had normal skin wound contraction [19], a

study applying SMαA fusion peptide to skin wounds in vivo significantly
inhibited rat skin wound contraction [49]. Third, the inconsistent results
of research focusing on fibroblasts or fibroblast-like cells in different
organs using Acta2 KO mice likely reflect the difference in the adapta
tion of these cells to Acta2 deletion. Unlike Acta2-null cardiac and skin
myofibroblasts that have normal contractility, a study using Acta2 KO
mice reported a reduction in the contractility of myofibroblasts derived
from hepatic stellate cells [20]. In the current study, significant in
creases in the transcription of Actg2 and Acta1, 2 other muscle actin
isoforms, were identified in Acta2-null cardiac myofibroblasts as
compared to WT cardiac myofibroblasts. Similar increases in the
expression of other muscle actin isoforms were also identified in Acta2null skin myofibroblasts [19]. Such increases were however not identi
fied in myofibroblasts derived from Acta2-null hepatic stellate cells [20].
Instead, an increase in the expression of cytoplasmic actin isoforms was
detected in these cells compared to their WT counterparts. It is possible
that without the guidance of stress fibers formed by muscle actin iso
forms the ability of non-muscle actin isoforms to form stress fibers is
relatively limited, which likely contributed to the more impacted con
tractile function of Acta2-null hepatic stellate cell-derived myofibro
blasts. Interestingly, besides the increased expression of non-SMαA
muscle actin isoforms, we found that the formation of stress fibers by
cytoplasmic actin isoforms was also increased in Acta2-null cardiac
myofibroblasts even though the changes in the expression of these actin
isoforms were rather small. Given the much lower expression level of
non-Acta2 muscle actin isoforms compared to cytoplasmic actin iso
forms even considering the compensatory increase in their expression,
cytoplasmic actin isoforms are likely also very critical for the normal
myofibroblast differentiation of Acta2-null cardiac fibroblasts. However,
it should be noted that due to the unavailability of antibodies specific to
several actin isoforms that work in western blot, we were not able to
accurately assess the levels of different actin isoforms incorporated into
filamentous actin strands.
SRF/MRTFA have been identified as key factors promoting myofi
broblast differentiation [39,40]. Our study confirmed the important role
of SRF/MRTFA in the expression of muscle actin isoforms and the for
mation of stress fibers in cardiac myofibroblasts. However, disruption of
the SRF/MRTFA signaling failed to affect the compensatory increase in
the expression of non-Acta2 actin isoforms despite the identification of
SRF binding motifs in and around these genes. Such a surprising
observation indicates the presence of other underlying mechanisms that
remain to be identified. Our ATACseq analysis also identified the
enrichment of some other motifs in actin genes such as the ones targeted
by basic helix-loop-helix transcription factors or bZIP domaincontaining transcription factors, whose possible contribution to the
compensatory increase of actin gene expression can be studied in the
future (Table S1). Other possible mechanisms also include post
transcriptional regulation that stabilizes the mRNA of actin genes.
Taken together, our results indicate that the expression of Acta2/
SMαA is not required for the myofibroblast differentiation of cardiac
fibroblasts and their activities in post-MI cardiac repair, which is at least
partially due to the compensatory increase in the expression of other
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Fig. 6. Knocking down of Mrtfa reduces the expression of muscle actin isoforms but does not affect the compensatory effects of non-SMαA actin isoforms in Acta2null cardiac myofibroblasts.
WT and Acta2-null cardiac fibroblasts were treated with Lenti-GFP or Lenti-shMrtfa and induced for myofibroblast differentiation using TGFβ for 2 days. (A-C) ICC
was performed to identify the expression of SMαA (A-B), total F-actin level (by phalloidin) (A), and total actin level (B). Scale bar: 40 μm (A), 100 μm (B). The
fluorescence intensity was measured using Image J (C). n = 4 for each group. Different letters indicate samples with significant differences (P < 0.05). (D) Realtime
PCR was performed to identify the transcription levels of Acta2, Acta1, Actb, Actc1, Actg1, and Actg2. n = 3 for each group. Different letters indicate samples with
significant differences (P < 0.05). (E-G) ICC was performed to identify the expression of SMαA (F-G), SkMαA/CMαA (F), SMα/γA (F), CyβA (G), and CyγA (G). The
fluorescence intensity was measured using Image J (E). Different letters indicate samples with significant differences (P < 0.05). n = 4 for each group. Scale bar: 100
μm (F) and 40 μm (G).

fibroblasts without MI. To increase the KO efficiency, we had to include
another course of tamoxifen treatment starting immediately before MI.
Even with prolonged tamoxifen treatment, suboptimal deletion of Acta2
in cardiac fibroblasts in the border zone was still observed in some mice.
It is possible that the lower vascular permeability in the border zone
compared to the scar area, owing to the lower grade of inflammation,

actin isoforms and the functional redundancy between SMαA and nonSMαA actin isoforms.
One limitation of this study was the suboptimal efficiency of Tcf21MerCreMer-mediated Acta2 KO, likely due to the relatively low activity
of Tcf21 promoter driving MerCreMer expression and the low chromatin
accessibility around the loxP sites when Acta2 is not expressed in cardiac
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caused a lower local concentration of active tamoxifen metabolites.
Moreover, we identified GFP− cardiac fibroblasts in the scar with normal
SMαA expression, which was likely also due to the presence of cardiac
fibroblasts of different lineages [50,51] and, again, the relatively low
efficiency of Tcf21-MerCreMer. The possible compensation of cardiac
fibroblasts without Acta2 deletion might have affected our ability to
reveal some subtle effects on post-MI hearts, which can only be detected
when Acta2 is deleted in all cardiac fibroblasts. A study employing a
strategy inhibiting the formation of stress fibers by all actin isoforms in
all cardiac fibroblasts is needed in the future to better decipher the
function of actin stress fibers in myofibroblasts and post-injury cardiac
repair.
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